Alagarsamy V, Meena S, Ramseshu K V, Solomon V R, Thirumurugan K, Dhanabal K, Murugan M
Medicinal Chemistry R&D Laboratory, Arulmigu Kalasalingam College of Pharmacy, Anand Nagar, Krishnankovil, India.
Eur J Med Chem. 2006 Nov;41(11):1293-300. doi: 10.1016/j.ejmech.2006.06.005. Epub 2006 Aug 22.
A variety of novel 2-methylthio-3-substituted-5,6,7,8-tetrahydrobenzo (b) thieno[2,3-d]pyrimidin-4(3H)-ones have been synthesized by reacting (2-methylthio-4-oxo-3H-5,6,7,8-tetrahydrobenzo (b) thieno[2,3-d]pyrimidin-3-yl)dithiocarbamic acid methyl ester (5) with a variety of amines. The starting material dithiocarbamate (5) was synthesized from 2-amino-3-carbethoxy-4,5,6,7-tetrahydrobenzo (b) thiophene (1) by a novel innovative route. The title compounds were investigated for analgesic, anti-inflammatory, ulcerogenicity index and antibacterial activities. While the test compounds exhibited significant activity, the compounds 1-methyl-3-(2-methylthio-4-oxo-3H-5,6,7,8-tetrahydrobenzo (b) thieno[2,3-d]pyrimidin-3-yl)thiourea (A1), 1-dimethyl-3-(2-methylthio-4-oxo-3H-5,6,7,8-tetrahydrobenzo (b) thieno[2,3-d]pyrimidin-3-yl)thiourea (A2), 1-diethyl-3-(2-methylthio-4-oxo-3H-5,6,7,8-tetrahydrobenzo (b) thieno[2,3-d]pyrimidin-3-yl)thiourea (A3) and 1-pyrrolidinyl-3-(2-methylthio-4-oxo-3H-5,6,7,8-tetrahydrobenzo (b) thieno[2,3-d]pyrimidin-3-yl)thiourea (A4) showed more potent analgesic activity and the compounds 1-dimethyl-3-(2-methylthio-4-oxo-3H-5,6,7,8-tetrahydrobenzo (b) thieno[2,3-d]pyrimidin-3-yl)thiourea (A2), 1-diethyl-3-(2-methylthio-4-oxo-3H-5,6,7,8-tetrahydrobenzo (b) thieno-[2,3-d]pyrimidin-3-yl)thiourea (A3) and 1-pyrrolidinyl-3-(2-methylthio-4-oxo-3H-5,6,7,8-tetrahydrobenzo (b) thieno[2,3-d] pyrimidin-3-yl)thiourea (A4) showed more potent anti-inflammatory activity than the reference standard diclofenac sodium.
通过使(2-甲硫基-4-氧代-3H-5,6,7,8-四氢苯并(b)噻吩并[2,3-d]嘧啶-3-基)二硫代氨基甲酸甲酯(5)与多种胺反应,合成了多种新型的2-甲硫基-3-取代-5,6,7,8-四氢苯并(b)噻吩并[2,3-d]嘧啶-4(3H)-酮。起始原料二硫代氨基甲酸盐(5)是通过一条新颖的创新路线由2-氨基-3-乙氧羰基-4,5,6,7-四氢苯并(b)噻吩(1)合成的。对标题化合物进行了镇痛、抗炎、致溃疡指数和抗菌活性研究。虽然测试化合物表现出显著活性,但化合物1-甲基-3-(2-甲硫基-4-氧代-3H-5,6,7,8-四氢苯并(b)噻吩并[2,3-d]嘧啶-3-基)硫脲(A1)、1-二甲基-3-(2-甲硫基-4-氧代-3H-5,6,7,8-四氢苯并(b)噻吩并[2,3-d]嘧啶-3-基)硫脲(A2)、1-二乙基-3-(2-甲硫基-4-氧代-3H-5,6,7,8-四氢苯并(b)噻吩并[2,3-d]嘧啶-3-基)硫脲(A3)和1-吡咯烷基-3-(2-甲硫基-4-氧代-3H-5,6,7,8-四氢苯并(b)噻吩并[2,3-d]嘧啶-3-基)硫脲(A4)显示出更强的镇痛活性,并且化合物1-二甲基-3-(2-甲硫基-4-氧代-3H-5,6,7,8-四氢苯并(b)噻吩并[2,3-d]嘧啶-3-基)硫脲(A2)、1-二乙基-3-(2-甲硫基-4-氧代-3H-5,6,7,8-四氢苯并(b)噻吩并[2,3-d]嘧啶-3-基)硫脲(A3)和1-吡咯烷基-3-(2-甲硫基-4-氧代-3H-5,6,7,8-四氢苯并(b)噻吩并[2,3-d]嘧啶-3-基)硫脲(A4)显示出比参比标准双氯芬酸钠更强的抗炎活性。